We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results.
- Authors
Diaz, George A.; Giugliani, Roberto; Gufon, Nathalie; Jones, Simon A.; Mengel, Eugen; Scarpa, Maurizio; Witters, Peter; Yarramaneni, Abhimanyu; Li, Jing; Armstrong, Nicole M.; Kim, Yong; Ortemann-Renon, Catherine; Kumar, Monica
- Abstract
Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results 2022;17:437. https://doi.org/10.1186/s13023-022-02587-0 1 Patient disposition Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Correction: Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results.
- Subjects
ENZYME replacement therapy; NIEMANN-Pick diseases; PEDIATRIC therapy; CHILD patients; TREATMENT effectiveness
- Publication
Orphanet Journal of Rare Diseases, 2023, Vol 18, Issue 1, p1
- ISSN
1750-1172
- Publication type
Correction Notice
- DOI
10.1186/s13023-023-02647-z